Walmart shares fell more than 8% intraday after the retailer's updated annual outlook failed to impress investors. CFO John David Rainey told analysts the new forecast reflects over $2bn of incremental costs this year from higher fuel prices and, compared with the firm's February outlook, an arguably weaker consumer environment—so management opted for only a modest guidance increase and a cautious stance.

At the World Robot Conference in Beijing Yizhuang on Aug. 19, Li Quan, committee member and deputy director of the Beijing Economic‑Technological Development Area management committee, unveiled "Beijing Jiyu," a plan for a human‑machine integrated embodied‑intelligence society. Beijing Yizhuang said it will speed development of 100 commercially deployable specialist robot models and push applications across 1,000 niche use cases; accelerate mass production of embodied‑intelligence robots at a 100,000‑unit scale; and build production capacity for 1 million sets of key core components.

【山东：重点发展针对治疗恶性肿瘤、血液病等的抗体药物】《山东省医药工业“十五五”发展行动方案（征求意见稿）》公开征求意见。其中提到，聚焦重大传染病、呼吸道感染、恶性肿瘤、耐药感染、自身免疫、代谢系统、中枢神经系统等疾病,加快发展单克隆抗体药物、双特异性抗体、三特异性抗体、抗体偶联药物、重组蛋白、细胞与基因治疗药物、创新疫苗以及海洋生物药等重点领域，推动核心技术攻关,加速产业化进程。其中，重点发展针对治疗恶性肿瘤、血液病、自身免疫疾病、代谢性疾病、眼科疾病、神经系统用药、心血管疾病和抗感染性疾病等的抗体药物。支持多功能抗体药物、抗体融合蛋白、纳米抗体、组合抗体、抗体复方制剂和高浓度制剂,以及新型ADC药物等创新技术平台发展,提高产业化能力。